Carthage School District announces inaugural Distinguished Tiger Alumni Award recipients
CARTHAGE, Mo. — The Carthage School District and the Distinguished Tiger Alumni Award Board recently announced inaugural recipients of the Distinguished Tiger Alumni Award — Brandon Weaver and Dr. Grant Williams. They will be honored Friday, Oct. 17, during the Carthage High School football game.
The award was established in honor of the late Carthage schoolteacher Caroline Tubbs and recognizes Carthage High School graduates who have made outstanding contributions in their fields and communities.
• Brandon Weaver, class of 2009, serves as a senior software engineer at Amazon One Medical. His career has included roles at Square, Gusto, Sony PlayStation and Cerner.
Brandon is also a featured speaker in the Ruby programming community, presenting worldwide from Japan to Brazil.
He also is an advocate for autism awareness and a supporter of education and athletics, including funding for classroom wish lists, the cross country program, providing a specialized wheelchair for a student-athlete, and covering a full year of college tuition for a student in need.
As a Carthage High School student, Weaver was involved in cross-country, track and field, SkillsUSA, jazz, concert and marching bands.
• Grant Williams, class of 2001, is an oncologist specializing in geriatric care. He is certified in internal medicine, oncology and geriatric medicine.
Williams currently serves as a professor and clinical researcher at the University of Alabama Birmingham, and has authored over 200 peer-reviewed scientific publications. His numerous honors include the Exceptional Care Provider Award, Teaching Excellence Award and Patient Excellence Award.
While at Carthage High School, Williams was active in tennis, jazz band, show choir, the math team, Spanish club, basketball and student council.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 days ago
- Yahoo
Carthage School District announces inaugural Distinguished Tiger Alumni Award recipients
CARTHAGE, Mo. — The Carthage School District and the Distinguished Tiger Alumni Award Board recently announced inaugural recipients of the Distinguished Tiger Alumni Award — Brandon Weaver and Dr. Grant Williams. They will be honored Friday, Oct. 17, during the Carthage High School football game. The award was established in honor of the late Carthage schoolteacher Caroline Tubbs and recognizes Carthage High School graduates who have made outstanding contributions in their fields and communities. • Brandon Weaver, class of 2009, serves as a senior software engineer at Amazon One Medical. His career has included roles at Square, Gusto, Sony PlayStation and Cerner. Brandon is also a featured speaker in the Ruby programming community, presenting worldwide from Japan to Brazil. He also is an advocate for autism awareness and a supporter of education and athletics, including funding for classroom wish lists, the cross country program, providing a specialized wheelchair for a student-athlete, and covering a full year of college tuition for a student in need. As a Carthage High School student, Weaver was involved in cross-country, track and field, SkillsUSA, jazz, concert and marching bands. • Grant Williams, class of 2001, is an oncologist specializing in geriatric care. He is certified in internal medicine, oncology and geriatric medicine. Williams currently serves as a professor and clinical researcher at the University of Alabama Birmingham, and has authored over 200 peer-reviewed scientific publications. His numerous honors include the Exceptional Care Provider Award, Teaching Excellence Award and Patient Excellence Award. While at Carthage High School, Williams was active in tennis, jazz band, show choir, the math team, Spanish club, basketball and student council.
Yahoo
05-06-2025
- Yahoo
Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby® XL System, the longest, largest and softest coil on the marketi. The Ruby XL System is designed to help physicians achieve more efficient embolization, potentially reducing radiation exposure, and optimizing outcomes — especially in large vessel and high-flow embolizationii. "We've engineered Ruby XL to deliver more volume per coil than any other coil on the market, which may result in cost savings," said Shruthi Narayan, President of Interventional Business at Penumbra, Inc. "Ruby XL embodies Penumbra's commitment to innovation, delivering mechanical occlusion through more volume without sacrificing softness or deliverability." The Ruby XL System introduces three unique technologies — Ruby XL, POD® XL, and Packing Coil XL — all of which can be delivered through a 0.035"+ diagnostic catheter. They have a primary diameter of .030" and are designed for procedural efficiency. These coils offer more volume (up to 40mm in size) and are available in extended lengths up to 70 cm. Engineered with a 3D complex shape, Ruby XL coil is designed to frame aneurysms in a variety of clinical applications. POD XL features a hybrid, multistage design and is engineered with three-in-one coil occlusion technology — an anchoring segment, a framing segment, and a dense filling segment. Designed for high flow vessels, POD XL offers smooth delivery and targeted vessel control. Packing Coil XL features an innovative liquid metal wave shape technology, which is designed to adjust dynamically to the size of any vessel (up to 70 cm length). Penumbra's Ruby portfolio of peripheral embolization products, now with Ruby XL System, provides physicians with one of the most expansive embolization offerings, enabling physicians to have the latest coil technologies and most extensive options for every case. For more information, please visit About PenumbraPenumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT™), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit and connect on Instagram, LinkedIn and X. Important Safety InformationAdditional information about Penumbra's products can be located on Penumbra's website at Caution: Federal (USA) law restrictions these devices to sale by or on the order of a physician. Prior to use, please refer to the Instructions for Use for complete product indications, contraindications, warnings, precautions, potential adverse events, and detailed instructions for use. Please visit for the complete IFU Summary Statements. The clinical results presented herein are for informational purposes only, and may not be predictive for all patients. Individual results may vary depending on patient-specific attributes and other factors. Forward-Looking Statements Except for historical information, certain statements in this press release are forward-looking in nature and are subject to risks, uncertainties and assumptions about us. Our business and operations are subject to a variety of risks and uncertainties and, consequently, actual results may differ materially from those projected by any forward-looking statements. Factors that could cause actual results to differ from those projected include, but are not limited to: failure to sustain or grow profitability or generate positive cash flows; failure to effectively introduce and market new products; delays in product introductions; significant competition; inability to further penetrate our current customer base, expand our user base and increase the frequency of use of our products by our customers; inability to achieve or maintain satisfactory pricing and margins; manufacturing difficulties; permanent write-downs or write-offs of our inventory or other assets; product defects or failures; unfavorable outcomes in clinical trials; inability to maintain our culture as we grow; fluctuations in foreign currency exchange rates; potential adverse regulatory actions; and the potential impact of any acquisitions, mergers, dispositions, joint ventures or investments we may make. These risks and uncertainties, as well as others, are discussed in greater detail in our filings with the Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 18, 2025. There may be additional risks of which we are not presently aware or that we currently believe are immaterial which could have an adverse impact on our business. Any forward-looking statements are based on our current expectations, estimates and assumptions regarding future events and are applicable only as of the dates of such statements. We make no commitment to revise or update any forward-looking statements in order to reflect events or circumstances that may change. ContactJennifer Heth Parinaz Farzin Penumbra, Inc. Merryman Communications jheth@ parinaz@ 510-995-9791 310.600.6746______________________ i Data as of May 2025, Ruby XL System is the largest and longest detachable embolization coil commercially available and the only 035 packing coil commercially available. ii Ruby XL is 2X larger than Ruby 020 coils and 3X larger than conventional 035 coils. Fewer coils used may potentially lead to reduced radiation exposure. View original content to download multimedia: SOURCE Penumbra, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
04-06-2025
- Yahoo
Brandon Weaver and Dr. Grant Williams receive Carthage alumni awards
CARTHAGE, Mo. — Two Carthage alumni are being honored for their actions in the world post-graduation. Officials with Carthage R-9 School District say the Distinguished Tiger Alumni Award Board have announced the inaugural recipients of their Distinguished Tiger Alumni Board, established in honor of Ms. Caroline Tubbs, a lifelong education advocate. The award was created to recognize Carthage High School graduates who have made outstanding contributions in their fields and communities. 2025 Distinguished Tiger Alumni Honorees Brandon Weaver – Class of 2009 Carthage officials say Brandon Weaver of Carthage's Class of 2009 has become a leader in the tech world and is described as a quiet force for good. Weaver currently serves as a Senior Software Engineer at Amazon One Medical. Past career roles have included working for Square, Gusto, Sony PlayStation, and Cerner. Weaver is also said to be a featured speaker in the Ruby programming community, giving presentations all over the world in places like Japan and Brazil. Weaver is known to be a passionate autism awareness advocate and has been a generous supporter of education and athletics; funding classroom wish lists and cross-country programs. Dr. Grant Williams – Class of 2001 Carthage officials say Dr. Grant Williams is a world-renowned oncologist, specializing in geriatric care. He is certified in internal medicine, oncology, and geriatric medicine. Dr. Williams currently serves as a professor and clinical researcher at the University of Alabama Birmingham. Dr. Williams has authored over 200 peer-reviewed scientific publications. Honors include the Exceptional Care Provider Award, Teaching Excellence Award, and Patient Excellence Award. Dr. Williams is known for his work in advancing care and dignity for older cancer patients. Dr. Williams' words for the students of today: 'Work hard and enjoy the journey.' Carthage officials say the two men will be honored at the Carthage High School football game on October 17, 2025.. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
